Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.43 |
| ▸ | MAPT | P10636 | 6/20 | 0.43 |
| ▸ | HPGD | P15428 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.43 |
| ▸ | RELA | Q04206 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29662030 | 1.00 | ALDH1A1 (0.43) | ALDH1A1MAPTHPGDKDM4ETP53 | |
| SCHEMBL22101156 | 0.95 | ALDH1A1 (0.40) | ALDH1A1MAPTHPGDKDM4ETP53 | |
| SCHEMBL10000978 | 0.95 | ADORA2A (0.41) | ALDH1A1MAPTHPGDKDM4ETP53 | |
| SCHEMBL10000997 | 0.88 | MEN1 (0.40) | ALDH1A1MAPTHPGDKDM4ETP53 | |
| SCHEMBL10000984 | 0.86 | MEN1 (0.43) | ALDH1A1MAPTHPGDKDM4EMAPK1 | |
| SCHEMBL347336 | 0.86 | ADORA1 (0.42) | ALDH1A1MAPTHPGDKDM4EMAPK1 | |
| SCHEMBL595855 | 0.86 | ADORA2A (0.45) | ALDH1A1MAPTHPGDKDM4EMAPK1 | |
| SCHEMBL10001008 | 0.85 | MEN1 (0.42) | ALDH1A1MAPTHPGDKDM4EMAPK1 | |
| SCHEMBL346750 | 0.85 | ADORA1 (0.41) | ALDH1A1MAPTHPGDKDM4EMAPK1 | |
| SCHEMBL13049750 | 0.84 | ALDH1A1 (0.45) | ALDH1A1MAPTHPGDKDM4ETP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3294727-B1 | ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER | NOVALED GMBH (DE) | 2021-08-04 | — | — | EP | claimed |
| EP-3294727-A1 | ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER | Novaled GmbH (DE) | 2018-03-21 | — | — | EP | claimed |
| EP-3147962-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Novaled GmbH (DE) | 2017-03-29 | — | — | EP | claimed |
| EP-3147961-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Novaled GmbH (DE) | 2017-03-29 | — | — | EP | claimed |
| WO-2016180891-A1 | ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER | NOVALED GMBH (DE) | 2016-11-17 | — | — | WO | claimed |
| EP-3093288-A1 | ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER | Novaled GmbH (DE) | 2016-11-16 | — | — | EP | claimed |
| EP-3035400-A1 | Organic light-emitting diode comprising electron transport layers with different matrix compounds | Novaled GmbH (DE) | 2016-06-22 | — | — | EP | claimed |
| US-20140073611-A1 | METHODS FOR DRUG SCREEN USING ZEBRAFISH MODEL AND THE COMPOUNDS SCREENED THEREFROM | NATIONAL TAIWAN UNIVERSITY (TW) | 2014-03-13 | — | — | US | claimed |
| EP-3252841-B1 | ORGANIC LIGHT EMITTING DIODE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2026-04-01 | — | — | EP | disclosed |
| US-12563963-B2 | Electron injection layer for an organic light-emitting diode (OLED) | NOVALED GMBH (DE) | 2026-02-24 | — | — | US | disclosed |
| US-12161044-B2 | Electron transport layer comprising a matrix compound mixture for an organic light-emitting diode (OLED) | NOVALED GMBH (DE) | 2024-12-03 | — | — | US | disclosed |
| US-20240298524-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NOVALED GMBH (DE) | 2024-09-05 | — | — | US | disclosed |
| CN-111900255-B | Organic light emitting device comprising a polar matrix, a metal dopant and a silver cathode | 诺瓦尔德股份有限公司 | 2024-03-15 | — | — | CN | disclosed |
| EP-3374538-B1 | PROCESS FOR MAKING A METAL CONTAINING LAYER | NOVALED GMBH (DE) | 2024-02-21 | — | — | EP | disclosed |
| WO-2011157385-A2 | ORGANIC LIGHT EMITTING DEVICE | NOVALED AG (DE) | 2011-12-22 | — | — | WO | disclosed |
| EP-2381502-A1 | Organic semiconducting layer | Novaled AG (DE) | 2011-10-26 | — | — | EP | disclosed |
| US-20110252985-A1 | ASPECTS OF A PRESS ASSEMBLY | ELIZABETH TOOLING, LLC | 2011-10-20 | — | — | US | disclosed |
| EP-2367215-A1 | An organic photoactive device | Novaled AG (DE) | 2011-09-21 | — | — | EP | disclosed |
| WO-2010075836-A2 | HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN ELECTRONIC AND OPTOELECTRONIC COMPONENTS | NOVALED AG (DE) | 2010-07-08 | — | — | WO | disclosed |
| WO-2010057471-A1 | CHINOXALINE COMPOUNDS AND SEMICONDUCTOR MATERIALS | NOVALED AG (DE) | 2010-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12563963-B2 | Electron injection layer for an organic light-emitting diode (OLED) | ICOSLG, OXA1L, OSBP2 | ALDH1A1 1592/4885MAPT 1706/4885HPGD 3839/4885 |
| US-20140073611-A1 | METHODS FOR DRUG SCREEN USING ZEBRAFISH MODEL AND THE COMPOUNDS SCREENED THEREFROM | PLOD3, MYOC, SLTM | ALDH1A1 1810/4885MAPT 2354/4885HPGD 3962/4885 |
| US-20240298524-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NNMT, PNN, PNMT | ALDH1A1 3986/4885MAPT 1529/4885HPGD 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.